Biomarkers in neonatology: The next generation of tests

Neonatology

Volumn 102, Issue 2, 2012, Pages 145-151

  Ng, Pak C ^a   Lam, Hugh S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Biomarkers; Newborns; Nucleic acids; Organ specific biomarker

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; CHEMOKINE; CREATINE KINASE MB; CREATININE; CYTOKINE; DNA; DNA FRAGMENT; FATTY ACID BINDING PROTEIN 2; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; LACTATE DEHYDROGENASE; MESSENGER RNA; MICRORNA; MICRORNA 208B; MICRORNA 499; NUCLEIC ACID; PROAPOLIPOPROTEIN CII; PROTEIN PRECURSOR; PROTEIN S 100; SERUM AMYLOID A; THROMBOPOIETIN; TRANSFORMING GROWTH FACTOR BETA; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; AUTOSOMAL DOMINANT DISORDER; BACTEREMIA; CELL FREE SYSTEM; CHORION VILLUS SAMPLING; CLINICAL PRACTICE; COLON CROHN DISEASE; CONNECTIVE TISSUE DISEASE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DNA SEQUENCE; FIBROSING ALVEOLITIS; GASTROINTESTINAL MOTILITY DISORDER; HEART MUSCLE ISCHEMIA; HEMOPHILIA; HIGH RISK PREGNANCY; HUMAN; HYDROCEPHALUS; ILEITIS; MASS SPECTROMETRY; MATERNAL BLOOD; METAGENOMICS; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEONATOLOGY; NEWBORN; NEWBORN DISEASE; NEWBORN SEPSIS; NEXT GENERATION SEQUENCING; NORMAL VALUE; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEOMICS; RESPIRATORY TRACT INFLAMMATION; REVIEW; RHESUS IMMUNIZATION; RHEUMATIC DISEASE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; TRANSCRIPTOMICS; TRISOMY 21; ULCERATIVE COLITIS;

BIOLOGICAL MARKERS; GENETIC MARKERS; GENOMICS; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; METABOLOMICS; NEONATAL SCREENING; NEONATOLOGY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84863094073     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000338587     Document Type: Review

References (51)

1. Ng PC, Lam HS: Biomarkers for late-onset neonatal sepsis: cytokines and beyond. Clin Perinatol 2010; 37: 599-610.
2. Ng PC: Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed 2004; 89:F229-F235.
3. Ng PC, Li K, Leung TF, Wong RP, Li G, Chui KM, Wong E, Cheng FW, Fok TF: Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6 and RANTES in preterm infants. Clin Chem 2006; 52: 1181-1189.
4. Ng PC, Li K, Chui KM, Leung TF, Wong RP, Chu WC, Wong E, Fok TF: IP-10 is an early diagnostic marker for identification of lateonset bacterial infection in preterm infants. Pediatr Res 2007,61: 93-98.
5. Lam HS, Wong SP, Cheung HM, Chu WC, Wong RP, Chui KM, Liu FY, Li K, Fok TF, Ng PC: Early diagnosis of intra-abdominal inflammation and sepsis by neutrophil CD64 expression in newborns. Neonatology 2011; 99: 118-124.
6. Ng PC, Cheng SH, Chui KM, Fok TF, Wong MY, Wong W, Wong RP, Cheung KL: Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1997; 77:F221-F227.
7. Ng PC, Li K, Wong RP, Chui KM, Wong E, Fok TF: Neutrophil CD64 expression: A sensitive diagnostic marker for late-onset nosocomial infection in very low birth weight infants. Pediatr Res 2002; 51: 296-303.
8. Ng PC, Li G, Chui KM, Chu WC, Li K, Wong RP, Fok TF: Quantitative measurement of monocyte HLA-DR expression in the identification of early-onset infection. Biol Neonate 2006; 89: 75-81.
9. Turunen R, Andersson S, Nupponen I, Kautiainen H, Siitonen S, Repo H: Increased CD11b-density on circulating phagocytes as an early sign of late-onset sepsis in extremely low birth weight infants. Pediatr Res 2005; 57: 270-275.
10. Chan KY, Lam HS, Cheung HM, Chan AK, Li K, Fok TF, Ng PC: Rapid identification and differentiation of Gram-negative and Grampositive bacterial bloodstream infections by quantitative polymerase chain reaction in preterm infants. Crit Care Med 2009; 37: 2441-2447.
11. Murch SH, MacDonald TT, Wood CB, Costeloe KL: Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax 1992; 47: 44-47.
12. Ng PC: Clinical trials for evaluating diagnostic markers of infection in neonates. Biol Neonate 2005; 87: 111-112.
13. Ng PC, Ang IL, Chiu RW, Li K, Lam HS, Wong RP, Chui KM, Cheung HM, Ng EW, Fok TF, Sung JJ, Lo YM, Poon TC: Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 2010; 120: 2989-3000.
14. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T: Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997; 337: 1648-1653.
15. El-Khuffash AF, Molloy EJ: Serum troponin in neonatal intensive care. Neonatology 2008; 94: 1-7.
16. Gunes T, Ozturk MA, Koklu SM, Narin N, Koklu E: Troponin-T levels in perinatally asphyxiated infants during the first 15 days of life. Acta Paediatr 2005; 94: 1638-1643.
17. Boo NY, Hafidz H, Nawawi HM, Cheah FC, Fadzil YJ, Abdul-Aziz BB, Ismail Z: Comparison of serum cardiac troponin T and creatine kinase MB isoenzyme mass concentrations in asphyxiated term infants during the first 48 h of life. J Paediatr Child Health 2005; 41: 331-337.
18. Costa S, Zecca E, De RG, De LD, Barbato G, Pardeo M, Romagnoli C: Is serum troponin T a useful marker of myocardial damage in newborn infants with perinatal asphyxia? Acta Paediatr 2007; 96: 181-184.
19. Clark SJ, Newland P, Yoxall CW, Subhedar NV: Concentrations of cardiac troponin T in neonates with and without respiratory distress. Arch Dis Child Fetal Neonatal Ed 2004; 89:F348-F352.
20. Kanda T, Fujii H, Tani T, Murakami H, Suda T, Sakai Y, Ono T, Hatukeyama K: Intestinal fatty acid binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 1996; 110: 339- 343.
21. Lieberman JM, Sacchettini J, Marks C, Marks WH: Human intestinal fatty acid binding protein: report of an intestinal ischemia. Surgery 1997; 121: 335-342.
22. Derikx JP, Evennett NJ, Degraeuwe PL, Mulder TL, van Bijnen AA, van Heurn LW, Buurman WA, Heineman E: Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotizing enterocolitis. Gut 2007; 56: 1473-1475.
23. Thuijls G, Derikx JP, van Wijck K, Zimmermann LJ, Degraeuwe PL, Mulder TL, Van der Zee DC, Brouwers HA, Verhoeven BH, van Heurn LW, Kramer BW, Buurman WA, Heineman E: Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 2010; 251: 1174-1180.
24. Merhar S: Biomarkers in neonatal posthemorrhagic hydrocephalus. Neonatology 2012; 101: 1-7.
25. Collard HR, Calfee CS, Wolters PJ, Song JW, Hong SB, Brady S, Ishizaka A, Jones KD, King Jr TE, Matthay MA, Kim DS: Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2010; 299:L3-L7.
26. Sasse S, Brand NJ, Kyprianou P, Dhoot GK, Wade R, Arai M, Periasamy M, Yacoub MH, Barton PJ: Troponin I gene expression during human cardiac development and in endstage heart failure. Circ Res 1993; 72: 932- 938.
27. Tsang JC, Lo YM: Circulating nucleic acids in plasma/serum. Pathology 2007; 39: 197- 207.
28. Santacroce R, Vecchione G, Tomaiyolo M, Sessa F, Sarno M, Colaizzo D, Grandone E, Margaglione M: Identification of fetal gender in maternal blood is a helpful tool in the prenatal diagnosis of haemophilia. Haemophilia 2006; 12: 417-422.
29. Finning K, Martin P, Daniels G: A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann NY Acad Sci 2004; 1022: 119-123.
30. Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M, Garcia-Hoyos M, Lorda- Sanchez I, Diaz-Recasens J, Ayuso C, Ramos C: Huntington disease-unaffected fetus diagnosed from maternal plasma using QFPCR. Prenat Diagn 2003: 23: 232-234.
31. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B: Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000; 46: 301- 302.
32. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, Haines CJ, Redman CW: Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999; 45: 184-188.
33. Leung TN, Zhang J, Lau TK, Chan LY, Lo YMD: Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 2001: 47: 137- 139.
34. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM: Maternal plasma fetal DNA as a marker for preterm labour. Lancet 1998; 352: 1904- 1905.
35. Holzgreve W, Ghezzi F, Di Naro E, Ganshirt D, Maymon E, Hahn S: Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 1998; 91: 669-672.
36. Lau TW, Leung TN, Chan LY, Lau TK, Chan KC, Tam WH, Lo YM: Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 2002; 48: 2141-2146.
37. Ohlin A, Backman A, Ewald U, Schollin J, Bjorkqvist M: Diagnosis of neonatal sepsis by broad-range 16S real-time polymerase chain reaction. Neonatology 2012; 101: 241-246.
38. Morowitz MJ, Denef VJ, Costello EK, Thomas BC, Poroyko V, Relman DA, Banfield JF: Strain-resolved community genomic analysis of gut microbial colonization in a premature infant. Proc Natl Acad Sci 2011; 108: 1128-1133.
39. Mai V, Young CM, Ukhanova M, Wang X, Sun Y, Casella G, Theriaque D, Li N, Sharma R, Hudak M, Neu J: Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One 2011; 6:e20647.
40. Voelkerding KV, Dames SA, Durtschi JD: Next-generation sequencing: from basic research to diagnostics. Clin Chem 2009; 54: 641-658.
41. Chiu RW, Cantor CR, Lo YM: Non-invasive prenatal diagnosis by single molecule counting technologies. Trends Genet 2009; 25: 324-331.
42. Schuster SC: Next-generation sequencing transforms today's biology. Nat Methods 2008; 5: 16-18.
43. Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, Lun FM, Go AT, Lau ET, To WW, Leung WC, Tang RY, Au-Yeung SK, Lam H, Kung YY, Zhang X, van Vugt JM, Minekawa R, Tang MH, Wang J, Oudejans CB, Lau TK, Nicolaides KH, Lo YM: Noninvasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. Br Med J 2011; 342:c7401 doi:10.1136/bmj.c7401.
44. Lambrechts AC, van't Veer LJ, Rodenhuis S: The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods. Ann Oncol 1998; 9: 1269-1276.
45. Chan RW, Wong J, Chan HL, Mok TS, Lo WY, Lee V, To KF, Lai PB, Rainer TH, Lo YM, Chiu RW: Aberrant concentrations of liverderived plasma albumin mRNA in liver pathologies. Clin Chem 2010; 56: 82-89.
46. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism and function. Cell 2004; 116: 281-297.
47. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, Fernandez MH, Tulbure D, Bueso-Ramos CE, Negrini M, Calin GA: MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 2009; 4:e7405.
48. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ: Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009; 106: 4402-4407.
49. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, Schroen B: Circulating microRNA-208b and microRNA- 499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 2010; 3: 499-506.
50. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518.
51. Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, Meltzer SJ, Brant SR, Kwon JH: Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 2010; 16: 1729-1738.